课题基金 / 基金详情

Brain mechanisms underlying reading improvement in post-stroke central alexia

Brain mechanisms underlying reading improvement in post-stroke central alexia
中风后中枢性失读症患者阅读改善的脑机制
批准号:
MR/K022563/1
负责人:
Alexander Leff
金额:
$72.75万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Central alexia is a common reading disorder caused by stroke and other forms of brain injury. Patients with central alexia are slow to read and make errors when they do so. They also have other problems with their language, most commonly speaking. Reading is important to most people so patients with central alexia have trouble returning to work, communicating by email or text, or simply reading for pleasure. The present research has four aims, described in detail below.1. Investigating the neural networks that support reading in patients with strokeDespite being a relatively common syndrome, there have been no functional brain imaging studies of central alexia. The primary aim of this research project is to use functional imaging to understand how preserved parts of the reading network can be encouraged by therapy to support reading again. This will be done with a state-of-the-art technique of network connectivity analysis using magnetoencephalography (MEG). MEG detects changes in brain activity with a highly precise time resolution at the millisecond range, which makes it ideal for investigating reading (words can be recognized at exposures of less than 20ms). Our previous research using MEG has identified brain areas that form the 'normal' reading network, and the proposed study will test how this model is affected in patients with central alexia.2. Developing a new treatment for central alexiaThere are currently no easy-to-access therapies for central alexia, and only two previous group-level studies of reading training have been conducted in this patient group. We plan to develop a computer-based reading training system to improve word reading speed in patients with central alexia. The research team has developed training software called 'iReadMore', which uses an intensive cross-modal approach (visual written words paired with auditory spoken words) to train word reading. This therapy has been shown to be effective in a group of patients with a similar form of reading disorder called pure alexia. The iReadMore software will be adapted to address the reading deficit in central alexia, and the research will test whether it leads to significant improvements in reading speed that makes a difference to patients' lives.3. Using brain stimulation to enhance behavioural trainingTranscranial direct current stimulation (tDCS) is a relatively new brain stimulation technique that has been shown to improve language performance in healthy controls and stroke patients. It has not yet been applied to the treatment of acquired reading disorders. The present study will test whether tDCS, delivered simultaneously with the 'iReadMore' reading training, significantly enhances the improvement in reading speed. To do this, the patients participating in the study will be split into two groups. One group will receive a 4-week block of training plus real tDCS first; and the other half will receive the same training but with 'sham' tDCS that is indistinguishable to the real brain stimulation. The two groups will then swap over in the second 4-week block, so that both groups ultimately get the same amount of treatment. Comparing the reading improvement over the real and sham tDCS blocks will demonstrate whether tDCS enhances the behavioural improvements in reading speed.4. Developing web-based therapy for central alexiaThere are currently no web-based therapy aids for patients with central alexia to access for themselves. . If 'iReadMore' proves effective and acceptable to patients then we plan to make it available via a web browser for suitable patients to use. We have a proven track record in this area and have already produced two high-quality, therapy "web-apps", www.readright.ucl.ac.uk and www.eyesearch.ucl.ac.uk, for patients with visual impairment after stroke.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cortex.2018.06.003
发表时间: 2018-09-01
期刊: CORTEX
影响因子: 3.6
作者: [Aguilar, Oscar M., Kerry, Sheila J., Leff, Alexander P.]
通讯作者: Leff, Alexander P.
DOI: 10.1016/j.nicl.2018.03.037
发表时间: 2018
期刊: NeuroImage. Clinical
影响因子: --
作者: [Hope TMH, Leff AP, Price CJ]
通讯作者: Price CJ
DOI: 10.1523/jneurosci.1426-18.2019
发表时间: 2019-05
期刊: The Journal of Neuroscience
影响因子: --
作者: [S. Kerry;O. M. Aguilar;W. Penny;J. Crinion;A. Leff;Z. Woodhead]
通讯作者: S. Kerry;O. M. Aguilar;W. Penny;J. Crinion;A. Leff;Z. Woodhead
Behavioural test battery for the Back of the Brain project
大脑后部项目的行为测试电池
DOI: 10.31234/osf.io/jyk9p
发表时间: 2021
期刊:
影响因子: --
作者: [Robotham R]
通讯作者: Robotham R
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: